EYE » Topics » Eye Care sales declined 72.5 percent to $19.0 million.
This excerpt taken from the EYE 8-K filed Aug 2, 2007.
Eye Care sales declined 72.5 percent to $19.0 million.
AMO estimated that the recall reduced eye care sales by approximately $54 million, including approximately $31 million in returns and an estimated $23 million in
lost sales. As a result of the sales returns, the company reported negative multipurpose sales of $7.8 million. The company incurred recall-related costs of approximately $27 million, which were recognized in cost of sales and SG&A expense.
Hydrogen peroxide sales declined 14.6 percent to $13.6 million, reflecting primarily the continued contraction of this market in Japan.
Bet you've never seen portfolio analytics like these.